Upgrade to SI Premium - Free Trial

ZS Pharma (ZSPH) Reports Interim Results From Long-Term Safety Study of ZS-9

November 9, 2015 7:14 AM
ZS Pharma, Inc. (Nasdaq: ZSPH) presented interim results from ZS005, a long-term safety and efficacy study of ZS-9 (sodium zirconium ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles